Trends in human immunodeficiency virus infection R. L. ColebundersB. G. WenigerJ. W. Curran Editorial Pages: 505 - 508
Flavobacterium meningosepticum infection in a neonatal ward B. BruunE. Tvenstrup JensenG. E. Andersen Article Pages: 509 - 514
Pharmacokinetics of ciprofloxacin in the elderly: Increased oral bioavailability and reduced renal clearance B. LjungbergI. Nilsson-Ehle Article Pages: 515 - 520
Mycobacterium chelonei infection of a Broviac catheter insertion site H. D. EnglerA. HassE. J. Bottone Notes Pages: 521 - 523
Serum bactericidal activity againstEnterobacteriaceae producing broad-spectrum beta-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined P. WeberY. BoussougantC. Carbon Notes Pages: 524 - 526
Detection of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals P. LegrandG. FournierA. Philippon Notes Pages: 527 - 529
Immune response to genital chlamydial infection and influence ofChlamydia pneumoniae (TWAR) antibodies S. OsserK. Persson Notes Pages: 532 - 535
In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil P. AngehrnP. HohlR. L. Then New Antimicrobial Agents Pages: 536 - 543
Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin A. L. BarryC. Thornsberrythe Collaborative Antimicrobial Susceptibility Testing Group New Antimicrobial Agents Pages: 544 - 549
Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria C. E. NordA. LindmarkI. Persson New Antimicrobial Agents Pages: 550 - 551
Antimicrobial activity and interaction of pefloxacin and its principal metabolites R. N. Jonesthe Collaborative Antimicrobial Susceptibility Testing Group New Antimicrobial Agents Pages: 551 - 556
Intraperitoneal penetration of cefpirome J. KaviJ. P. AshbyI. A. Donovan New Antimicrobial Agents Pages: 556 - 558
Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics B. A. Nies New Antimicrobial Agents Pages: 558 - 561
Treatment of chronic experimentalStaphylococcus aureus osteomyelitis with LY146032 and vancomycin Q. N. LuuT. B. BuxtonJ. P. Rissing New Antimicrobial Agents Pages: 562 - 563
Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents M. PfallerR. GordeeR. Wenzel New Antimicrobial Agents Pages: 564 - 567
Human immunodeficiency virus type 2 in Spain V. SorianoJ. TorA. Ribera Letters To The Editor Pages: 568 - 568
V-factor (NAD) independentHaemophilus parainfluenzae recovered from a human genital ulcer R. GromkovaY. DangorS. D. Miller Letters To The Editor Pages: 569 - 569
Isolation ofWeeksella virosa (formerly CDC group IIf) from a vaginal sample J. ReinaJ. GilP. Alomar Letters To The Editor Pages: 569 - 570
Comparison of culture, indirect immunofluorescence and dark-field microscopy for detection of spirochetes fromIxodes ricinus ticks R. GustafsonA. GardulfB. Svenungsson Letters To The Editor Pages: 570 - 572
T-cell subpopulations of fetuses infected byToxoplasma gondii B. LecolierS. MarionG. Sarrot Letters To The Editor Pages: 572 - 573
Rapid antibody response following intrasplenic inoculation of formalin-treatedToxoplasma gondii into mice I. Humphery-SmithM. DémazureC. Chastel Letters To The Editor Pages: 573 - 575
Relationship betweenToxoplasma gondii antibodies and blood group T. MidtvedtL. Vaage Letters To The Editor Pages: 575 - 576
Subdiaphragmatic gas in hepatic hydatid disease R. G. MastertonC. BridgerR. Bury Letters To The Editor Pages: 576 - 577